NEW YORK (GenomeWeb) – IDbyDNA announced today its partnership with ARUP Laboratories to develop and commercialize next-generation-sequencing (NGS) infectious disease testing using metagenomics, aiming to yield results that are more comprehensive, sensitive, and accurate than current tests.

Conventional testing procedures are normally restricted to requesting specific pathogens and can return a high percentage of negative results, leaving clinicians without crucial information required to efficiently diagnose and treat their patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.